XML 16 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenue    
Product sales, net $ 11,281,886 $ 10,482,005
Cost of products sold 4,312,507 4,175,533
Gross profit 6,969,379 6,306,472
Selling, general and administrative expenses 11,930,951 11,549,961
Research and development expenses 272,746 1,270,471
Total operating expenses 12,203,697 12,820,432
Loss from operations (5,234,318) (6,513,960)
Other expenses (4,930) (5,088)
Interest income 9,298 1,285
Loss before provision for income tax and equity in net earnings of equity investments (5,229,950) (6,517,763)
(Provision) benefit for income tax (19,093) 19,101
Loss before equity in net earnings of equity investments (5,249,043) (6,498,662)
Loss on earnings from China Joint Venture (120,510) (795,827)
Net loss (5,369,553) (7,294,489)
Net loss attributable to noncontrolling interests (182,760) (1,347,982)
Net loss attributable to Milestone Scientific Inc. $ (5,186,793) $ (5,946,507)
Net loss per share applicable to common stockholders—    
Basic (in dollars per share) $ (0.16) $ (0.22)
Diluted (in dollars per share) $ (0.16) $ (0.22)
Weighted average shares outstanding and to be issued—    
Basic (in shares) 32,703,897 26,966,988
Diluted (in shares) 32,703,897 26,966,988